Global Exporter & Bulk Supplier of Sunitcap 12.5mg Capsules
🌍 Your Strategic Partner for Oncology Procurement
Are you looking for a reliable international source for Sunitcap 12.5mg Capsules? Ernest Oncology (A division of Ernest Pharmaceutical Pvt. Ltd.) is a leading global exporter of targeted therapy medications. We specialize in the high-standard distribution of Sunitinib 12.5mg to specialized medical institutions, oncology clinics, and pharmaceutical wholesalers in the USA, UK, Australia, and South Africa
.
🔬 1. Product Insights: Sunitcap 12.5mg Capsules
Sunitcap 12.5mg is an oral multi-kinase inhibitor containing Sunitinib Malate, primarily used in the management of specific solid tumors.
Active Ingredient: Sunitinib (12.5mg)
Therapeutic Class: Tyrosine Kinase Inhibitor (TKI) / Antineoplastic Agent
Mechanism of Action: It works by blocking multiple enzymes (kinases) involved in the growth, signaling, and blood vessel formation (angiogenesis) of cancer cells, thereby slowing down tumor progression.
Common Indications:
- RCC: Advanced Renal Cell Carcinoma (Kidney Cancer).
- GIST: Gastrointestinal Stromal Tumors after disease progression on or intolerance to Imatinib.
- pNET: Advanced Pancreatic Neuroendocrine Tumors.
PRESCRIPTION MEDICINE IS : YES
Disclaimer: Sunitcap 12.5mg Capsule is a high-potency targeted antineoplastic prescription medication. It must only be used under the direction and supervision of a registered oncologist. Patients require regular clinical monitoring while on this therapy. Ernest Oncology is a global supplier and exporter; this content is for B2B informational purposes and does not replace professional medical advice.
📞 Contact Ernest Oncology — Medicine Exporter
(GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.)
🌐 Websites:
✉️ Contact Channels:
📧 Email Inquiries: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 Call / WhatsApp: +91 93599 02383
🔗 WhatsApp Direct Link: https://wa.me/919359902383
